MAVEN INCOME AND GROWTH VCT PLC Maven Income and Growth VCT PLC Share Price
Equities
MIG1
GB0004122858
Investment Management & Fund Operators
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38 GBX | 0.00% |
|
0.00% | 0.00% |
| 01-16 | Alpha Core Strategies Fund announces an Equity Buyback. | CI |
| 01-16 | Alpha Core Strategies Fund authorizes a Buyback Plan. | CI |
| Sales 2022 | 4.59M 5.73M 459M | Sales 2023 | 3.13M 3.91M 313M | Capitalization | 54.94M 68.63M 5.49B |
|---|---|---|---|---|---|
| Net income 2022 | 2M 2.5M 200M | Net income 2023 | 1M 1.25M 100M | EV / Sales 2022 | 8.19 x |
| Net cash position 2022 | 23.34M 29.15M 2.33B | Net cash position 2023 | 9.83M 12.28M 983M | EV / Sales 2023 | 14.4 x |
| P/E ratio 2022 |
20.3
x | P/E ratio 2023 |
40.4
x | Employees | - |
| Yield 2022 |
5% | Yield 2023 |
5.49% | Free-Float | 99.61% |
More Fundamentals
* Assessed data
More news
| 6 months | -2.56% |
1 week
37.00
38.00
1 month
37.0039.00
Current year
37.0039.00
1 year
36.2042.00
3 years
36.2047.00
5 years
36.2047.00
10 years
36.2075.00
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 64 | 28/02/07 | |
| Director/Board Member | 61 | 18/01/00 | |
Alison Fielding
BRD | Director/Board Member | 59 | 31/12/18 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 38 | 0.00% | 0 |
| 25/04/24 | 38 | 0.00% | 3,491 |
| 24/04/24 | 38 | 0.00% | 0 |
| 23/04/24 | 38 | 0.00% | 10,338 |
| 22/04/24 | 38 | 0.00% | 0 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes
Maven Income and Growth VCT PLC is a United Kingdom-based generalist venture capital trust (VCT). The investment objective of the Company is to generate long-term investment returns with tax-free capital gains and regular tax-free dividend income for its shareholders. The Company seeks to invest in a diversified portfolio of smaller United Kingdom growth companies, either unquoted or traded on the Alternative Investment Market (AIM). It invests in various sectors, such as software; business services; pharmaceuticals, biotechnology and healthcare; data analytics; marketing and advertising technology; and pharmaceuticals, biotechnology and healthcare, among others. Maven Capital Partners UK LLP serves as manager for the Company.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 76.83M | |
| +31.41% | 12.02B | |
| +14.40% | 3.06B | |
| +2.96% | 1.42B | |
| -8.46% | 1.22B | |
| +1.15% | 616M | |
| -10.84% | 579M | |
| +35.79% | 577M | |
| -4.17% | 492M | |
| +33.85% | 488M |
- Stock Market
- Equities
- MIG1 Stock
